Skip to main content
. 2022 Jan 28;30(1):66–74. doi: 10.5606/tgkdc.dergisi.2022.20912

Table 3. Five-year survival rates of patients.

Variables General VATS Open thoracotomy VATS and Open thoracotomy
5-year OS p 5-year OS 5-year OS
% % % p
Total 67.0 - 74.1 65.2 0.055
Age (year)   0.31      
<60 69.4   88.4 66.9 0.06
>60 65.3   69.0 63.7 0.24
Sex   0.015      
Male 65.0   68.8 63.9 0.25
Female 76.6   92.9 72.3 0.11
Comorbidity   0.35      
No 68.0   77.9 65.7 0.041
Yes 65.2   71.5 64.0 0.42
Neoadjuvant therapy   0.024      
No 68.7   74.7 66.9 0.094
Yes 54.5   50.0 55.1 0.49
Type of resection   0.84      
Lobectomy 66.8   73.5 64.9 0.086
Bilobectomy 76.8   100 67.8 0.23
Histology   0.063      
Non-adenocarci nom a 70.0   78.0 68.6 0.33
Adenocarcinoma 63.8   70.1 61.1 0.057
Size (cm)   0.094      
<3 69.8   85.4 66.6 0.097
3-7 63.7   43.1 64.4 0.75
>7 63.1   - 63.1 -
Lymph node involvement   <0.0001      
(n)          
No 73.1   76.2 71.7 0.2
Yes 48.8   65.7 48.9 0.72
VATS: Video-assisted thoracic surgery; OS: Overall survival; Bold values represent statistically significant outcomes.